ZERLINDA

This brand name is authorized in Ireland, Poland, Romania.

Active ingredients

The drug ZERLINDA contains one active pharmaceutical ingredient (API):

1	Zoledronic acid UNII 6XC1PAD3KF - ZOLEDRONIC ACID
	Zoledronic acid belongs to the class of bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclastic bone resorption.
	Read more about Zoledronic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZERLINDA Solution for infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M05BA08	Zoledronic acid	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
PL	Rejestru Produktów Leczniczych	100315278
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68080001, W68080002